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Background: Recently, the first plasmid-mediated colistin-resistance gene, mcr-1, was reported. Colistin is
increasingly used as an antibiotic of last resort for the treatment of infections caused by carbapenem-resistant
bacteria, which have been rapidly disseminating worldwide in recent years.
Objectives: The reported carriage rate of mcr-1 in humans remains sporadic thus far, except for those reported in
Chinese populations. We aimed to determine its presence in the faecal metagenomes of healthy Dutch travellers
between 2010 and 2012.
Methods: Faecal metagenomic DNA of pre- and post-travel samples from 122 healthy Dutch long-distance
travellers was screened for the presence of mcr-1 using a TaqMan quantitative PCR assay, which was designed
in this study. All positive samples were confirmed by sequencing of the amplicons.
Results: The mcr-1 gene was detected in 6 (4.9%, 95% CI¼2.1%–10.5%) of 122 healthy Dutch long-distance
travellers after they had visited destinations in South(-east) Asia or southern Africa between 2011 and 2012. One
of these participants was already found to be positive before travel.
Conclusions: Our study highlights the potential of PCR-based targeted metagenomics as an unbiased and
sensitive method to screen for the carriage of the mcr-1 gene and suggests that mcr-1 is widespread in various
parts of the world. The observation that one participant was found to be positive before travel suggests that
mcr-1 may already have disseminated to the microbiomes of Dutch residents at a low prevalence, warranting
a more extensive investigation of its prevalence in the general population and possible sources.
Introduction
Colistin is increasingly used as an antibiotic of last resort for the
treatment of infections caused by carbapenem-resistant bacteria.
Therefore, the finding of plasmid-mediated colistin resistance has
rightfully drawn renewed attention to colistin resistance.1,2
Considering the successful dissemination of other resistance
mechanisms by horizontal gene transfer,3 the mobile colistin-
resistance gene mcr-1 may have major implications for public
health. After the initial report by Liu et al.4 describing a high preva-
lence of mcr-1 in Escherichia coli isolates from pigs at slaughter
(21%) and a relatively lower prevalence in E. coli and Klebsiella
pneumoniae isolates from human patients (1.4% and 0.7%,
respectively), more studies have been conducted investigating
the worldwide spread of this gene.2,5 – 12 While the rates of
mcr-1-positive strains isolated from animals or food were quite
high in some of these studies,11,12 the reported carriage rate in
humans thus far remains sporadic except for those reported in
Chinese populations.2 In contrast to most studies to date, which
have mostly screened existing collections of cultured isolates or
mined metagenomic sequencing data, we applied a PCR-based
targeted metagenomic approach to detect the presence of
the mcr-1 gene in the faecal metagenomes of healthy Dutch
travellers between 2010 and 2012.
Materials and methods
In this study we used faecal samples from 122 healthy Dutch long-
distance travellers previously recruited in a prospective travel cohort
study.13 Processing and DNA extraction of faecal samples was described
# The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.
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previously.13 To use a targeted metagenomics approach, a TaqMan quan-
titative PCR (qPCR) assay was developed. In addition to the primers
described by Liu et al.,4 generating a 309 bp product, a dual-labelled
probe was designed [5′-TTGACCGCGACCGCCAATCTTA-3′ with FAM reporter
and a Black Hole Quencher (BHQ1)] (Sigma-Aldrich, St Louis, MO, USA).
Amplifications were performed on a 7900HT Fast Real-Time PCR System
(Thermo Fisher Scientific, Waltham, MA, USA) in 25 mL reactions containing
12.5 mL of ABsolute QPCR ROX Mix (Thermo Fisher Scientific), 5 mL of tem-
plate DNA, 300 nM of both primers and 200 nM of probe. Thermal cycling
consisted of 15 min at 958C, followed by 45 cycles of 15 s at 958C and
1 min at 608C. To assess the efficiency of the assay, standard curves
were created using a control plasmid. This plasmid was constructed by
cloning the corresponding PCR amplicon into a pGEM-T easy vector
(Promega Corporation, Madison, WI, USA). Standard curves were then gen-
erated by triplicate measurements of serial dilutions of the control plasmid
spiked into three different (faecal) metagenomic DNA samples.
All faecal samples indicated as positive by qPCR were confirmed by
sequencing using the PCR primers and a BigDye Terminator v1.1 Cycle
Sequencing Kit (Thermo Fisher Scientific) on an ABI 3730 DNA Analyzer
(Thermo Fisher Scientific) and were analysed using NCBI’s Basic Local
Alignment Search Tool (BLAST).
Faecal samples that tested positive for the mcr-1 gene were streaked on
to lysogenic broth agar plates containing colistin (2 mg/L) and vancomycin
(50 mg/L) and incubated overnight at 378C to obtain colistin-resistant iso-
lates. Once the cultures were visually confirmed to be pure and resistant to
colistin, they were streaked on to blood agar plates (Becton-Dickinson,
Franklin Lakes, NJ, USA) for identification by MALDI-TOF MS (bioMérieux,
Marcy-l′Étoile, France) and antibiotic susceptibility testing using the BD
Phoenix Automated Microbiology System (Becton-Dickinson) and Etest for
colistin (bioMérieux); results were interpreted according to EUCAST.14
PFGE was performed on colistin-resistant E. coli isolates according
to the rapid procedure described previously.15 After 15 min of pre-
incubation in 200 mL of the restriction enzyme buffer, supplemented
with 100 mg/mL BSA, 2×5 mm thick slices of each plug were incubated
at 378C for 3 h with 30 U of XbaI enzyme in 100 mL of the restriction
enzyme buffer+100 mg/mL BSA. Fragments were separated on a 1%
SeaKem Gold agarose gel for 16 h. Salmonella serotype Braenderup
H9812 strain (ATCC strain BAA-664) was included as a reference strain.
The resulting gel was analysed with BioNumerics v7.5 and according to
the criteria of Tenover et al.16 MLST was performed according to Wirth
et al.17 Real-time PCR to detect blaCTX-M, qnrA, qnrB and qnrS genes in
mcr-1-harbouring isolates obtained in this study was performed as
described previously.13
Results
The designed mcr-1 assay was linear over 8 log dilutions of a con-
trol plasmid (Ct value range¼10.7 –33.5, maximum variation
between replicates¼0.42 Ct, slope¼23.378, R
2¼0.999), with
an efficiency of 98%. While concentrations of 5 plasmid copies
per reaction were no longer within the linear reach and showed
greater variation between replicates (Ct value¼36.4–37.7), they
were none the less reproducibly detectable. Measuring log dilu-
tions of the control plasmid spiked into DNA isolated from faecal
samples yielded a similar efficiency (slope¼23.341, R2¼0.999)
and sensitivity.
Screening of the faecal metagenomes of 122 travellers, before
and after travel, yielded seven samples positive for mcr-1 accord-
ing to qPCR (Ct value range¼24.1–40.2). Positive samples were all
confirmed by sequencing, showing high specificity of the PCR
assay (no false-positives were observed). For one participant,
the mcr-1 gene was detected in both the pre- and post-travel
sample, whereas for five other participants only the post-travel
sample was found to be positive, reflecting a post-travel preva-
lence of 4.9% (95% CI¼2.1%–10.5%) and acquisition rate of
4.1% (95% CI¼1.5%–9.6%) (Table 1). Half of the participants
who were positive for mcr-1 after travel had used antibiotics
in the 3 months preceding post-travel sampling (Table 1)
as compared with only 9.5% of participants negative for
mcr-1 (P,0.05).
The seven faecal samples of participants that tested positive
for mcr-1 with the targeted metagenomic approach were
cultured to obtain colistin-resistant Gram-negative bacteria.
Three mcr-1-harbouring, colistin-resistant E. coli isolates were
obtained, which are specified in Table 2. Although two of
these isolates were obtained from participant 6 [one before travel
(isolate 6T0) and one after travel (isolate 6T1)], these strains were
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1 55 male 5 minocycline Thailand May 2011 — mcr-1, qnrS
2 69 male 21 — Vietnam March 2011 qnrB mcr-1, CTX-M-2a,
CTX-M-9a, qnrA,
qnrB, qnrS
3 24 female 18 — Indonesia June 2011 — mcr-1, qnrS
4 26 female 21 — Tanzania June 2011 — mcr-1, qnrS
5 40 female 35 trimethoprim/
sulfamethoxazole
Thailand and Vietnam January 2012 — mcr-1, qnrB, qnrS
6 46 female 10 azithromycin India May 2012 mcr-1, qnrB mcr-1, qnrB, qnrS
aCTX-M phylogenetic group as determined by qPCR.
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distinct as determined by PFGE (data not shown) and MLST
(Table 2) and showed different antibiotic susceptibility testing
profiles (Table 2). Considering the acquisition of other resistance
genes in the faecal microbiomes mentioned in Table 1, the iso-
lated mcr-1-positive strains were also tested for the presence of
blaCTX-M, qnrA, qnrB and qnrS genes, but were negative.
Discussion
In our study, we report the occurrence of mcr-1 in the faecal
microbiota of Dutch international travellers using a targeted,
PCR-based metagenomic approach. Bontron et al.18 previously
described a SYBR Green-based real-time PCR to overcome false-
positive signals, which were observed with earlier published pri-
mers. However, since metagenomic DNA samples are more
prone to induce unspecific amplification due to the diversity of
DNA templates present compared with, for example, DNA isolated
from bacterial isolates, we opted for the addition of a TaqMan
probe in our assay. The designed TaqMan assay was shown to
be both specific and sensitive when used on isolated as well as
on metagenomic samples.
Bacteria harbouring mcr-1 could be cultured from some, but
not all, investigated faecal samples that tested positive for this
gene by qPCR. Likely, the (viable) bacterial load in the samples
was too low or was negatively affected by storage, as there
was also an absence of growth of any other colistin-resistant
Gram-negative bacteria. Alternatively, the mcr-1 genes could be
non-functional, non-expressed or originate from organisms not
readily cultivable with the currently used methods.
This study shows a post-travel prevalence (4.9%) of mcr-1 in
the microbiota of travellers. In line with a recent other Dutch
study,19 the pre-travel prevalence in the present study was
much lower (0.8%). The observed acquisition rate suggests, how-
ever, that mcr-1 has already disseminated at high rates in certain
parts of the world and travel to such high-risk areas is a risk factor
for its acquisition and further dissemination. Concerning this,
Arcilla et al.20 previously reported that 6 (,1%) of 633
ESBL-producing Enterobacteriaceae that were acquired by Dutch
international travellers were positive for mcr-1. In our study, we
did not select for travel-associated ESBL-producing isolates, but
rather screened all faecal metagenomes, which most likely
accounts for the higher acquisition rate.
Many studies on mcr-1 have investigated collections of ESBL-
producing Enterobacteriaceae and it has been reported that
mcr-1-positive isolates often carry multiple resistance genes,
including genes encoding ESBLs.2 For this reason, we investigated
the antibiotic resistance profiles of the three isolates obtained
from our study population. These were all determined to be
Table 2. MLST and antibiotic susceptibility testing profiles of mcr-1-harbouring E. coli isolated from Dutch human faecal samples
Isolate ID (MLST)
2T1 (ST 1011) 6T0 (ST 744) 6T1 (ST 80)
MIC (mg/L) S/Ra MIC (mg/L) S/R MIC (mg/L) S/R
Amikacin ≤4 S ≤3 S ≤4 S
Amoxicillin/clavulanate 32/2 R 4/2 S 4/2 S
Ampicillin >8 R >8 R ≤2 S
Cefepime ≤1 S ≤1 S ≤1 S
Cefoxitin ≤4 S ≤4 S ≤4 S
Ceftazidime ≤1 S ≤1 S ≤1 S
Ceftriaxone ≤1 S ≤1 S ≤1 S
Cefuroxime 4 S 4 S ≤2 S
Ciprofloxacin >1 R >1 R ≤0.25 S
Colistinb 3 R 3 R 3 R
Ertapenem ≤0.25 S ≤0.25 S ≤0.25 S
Gentamicin ≤1 S ≤1 S ≤1 S
Imipenem ≤0.25 S ≤0.25 S ≤0.25 S
Levofloxacin >2 R >2 R ≤0.5 S
Meropenem ≤0.125 S ≤0.125 S ≤0.25 S
Piperacillin >16 R >16 R ≤4 S
Piperacillin/tazobactam ≤4/4 S ≤4/4 S ≤4/4 S
Temocillin 16 — ≤4 — ≤4 —
Tigecycline ≤0.5 S ≤0.5 S ≤0.5 S
Tobramycin 2 S ≤1 S ≤1 S
Trimethoprim/sulfamethoxazole >4/76 R >4/76 R ≤1/19 S
R, resistant; S, susceptible; —, no breakpoint available.
Bold formatting indicates resistance.
aInterpretation according to EUCAST clinical breakpoints.
bAs determined by Etest.
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non-ESBL producers, however. Notably, one isolate (6T1) was
susceptible to all tested antibiotics other than colistin. To this
end, there is a need for studies without selections based on
resistance profiles to define this relationship more clearly.
In conclusion, we report a relatively high mcr-1 prevalence in
microbiomes of Dutch residents after international travel, high-
lighting the potential of PCR-based targeted metagenomics as
an unbiased and sensitive method to screen for the carriage of
mcr-1. The acquisition rates show that travel contributes to the
dissemination of mcr-1. Furthermore, the participant who was
mcr-1-positive before travel indicates that mcr-1 may already
be present in the microbiomes of Dutch residents at a low
prevalence, warranting further investigation of its prevalence in
the general population and possible sources.
Funding
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